Afterload reduction

A comparison of captopril and nifedipine in dilated cardiomyopathy

P. G. Agostoni, N. de Cesare, E. Doria, A. Polese, G. Tamborini, M. D. Guazzi

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

Nifedipine and captopril are potent vasodilators and may be expected to help left ventricular failure by reducing afterload. Nifedipine (20 mg three times a day) and captopril (50 mg three times a day) were added to an optimal regimen of digitalis and diuretics in a double blind crossover trial in 18 cases of dilated cardiomyopathy. New York Heart Association functional class rating symptoms and exercise tolerance times improved on captopril but not on nifedipine. The reduction in pulmonary capillary wedge pressure and the increase of cardiac output on captopril indicated that the augmented functional capacity may have resulted in part from an improved performance of the left ventricle. Although there were comparable decreases in systemic vascular resistance and presumably in impedence to ejection by the left ventricle on both drugs, the dimensions of the ventricular cavity were found to be reduced by captopril and augmented by nifedipine, and only captopril reduced the afterload (wall stress). In addition, the force-length relation (between left ventricular end systolic stress and end systolic diameter) was shifted to the left of baseline by captopril and to the right by nifedipine, suggesting that muscle contractility was reduced by nifedipine and not by captopril. These results suggest that nifedipine and captopril have different effects on afterload and contractility and these may account for the different effects of these drugs on the performance of the heart and clinical responses.

Original languageEnglish
Pages (from-to)391-399
Number of pages9
JournalBritish Heart Journal
Volume55
Issue number4
Publication statusPublished - 1986

Fingerprint

Captopril
Dilated Cardiomyopathy
Nifedipine
Heart Ventricles
Pulmonary Wedge Pressure
Exercise Tolerance
Digitalis
Vasodilator Agents
Diuretics
Pharmaceutical Preparations
Cardiac Output
Vascular Resistance
Cross-Over Studies
Muscles

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Afterload reduction : A comparison of captopril and nifedipine in dilated cardiomyopathy. / Agostoni, P. G.; de Cesare, N.; Doria, E.; Polese, A.; Tamborini, G.; Guazzi, M. D.

In: British Heart Journal, Vol. 55, No. 4, 1986, p. 391-399.

Research output: Contribution to journalArticle

Agostoni, P. G. ; de Cesare, N. ; Doria, E. ; Polese, A. ; Tamborini, G. ; Guazzi, M. D. / Afterload reduction : A comparison of captopril and nifedipine in dilated cardiomyopathy. In: British Heart Journal. 1986 ; Vol. 55, No. 4. pp. 391-399.
@article{df79e83264a94ea5b29bf604548601a3,
title = "Afterload reduction: A comparison of captopril and nifedipine in dilated cardiomyopathy",
abstract = "Nifedipine and captopril are potent vasodilators and may be expected to help left ventricular failure by reducing afterload. Nifedipine (20 mg three times a day) and captopril (50 mg three times a day) were added to an optimal regimen of digitalis and diuretics in a double blind crossover trial in 18 cases of dilated cardiomyopathy. New York Heart Association functional class rating symptoms and exercise tolerance times improved on captopril but not on nifedipine. The reduction in pulmonary capillary wedge pressure and the increase of cardiac output on captopril indicated that the augmented functional capacity may have resulted in part from an improved performance of the left ventricle. Although there were comparable decreases in systemic vascular resistance and presumably in impedence to ejection by the left ventricle on both drugs, the dimensions of the ventricular cavity were found to be reduced by captopril and augmented by nifedipine, and only captopril reduced the afterload (wall stress). In addition, the force-length relation (between left ventricular end systolic stress and end systolic diameter) was shifted to the left of baseline by captopril and to the right by nifedipine, suggesting that muscle contractility was reduced by nifedipine and not by captopril. These results suggest that nifedipine and captopril have different effects on afterload and contractility and these may account for the different effects of these drugs on the performance of the heart and clinical responses.",
author = "Agostoni, {P. G.} and {de Cesare}, N. and E. Doria and A. Polese and G. Tamborini and Guazzi, {M. D.}",
year = "1986",
language = "English",
volume = "55",
pages = "391--399",
journal = "British Heart Journal",
issn = "0007-0769",
publisher = "BMJ Publishing Group",
number = "4",

}

TY - JOUR

T1 - Afterload reduction

T2 - A comparison of captopril and nifedipine in dilated cardiomyopathy

AU - Agostoni, P. G.

AU - de Cesare, N.

AU - Doria, E.

AU - Polese, A.

AU - Tamborini, G.

AU - Guazzi, M. D.

PY - 1986

Y1 - 1986

N2 - Nifedipine and captopril are potent vasodilators and may be expected to help left ventricular failure by reducing afterload. Nifedipine (20 mg three times a day) and captopril (50 mg three times a day) were added to an optimal regimen of digitalis and diuretics in a double blind crossover trial in 18 cases of dilated cardiomyopathy. New York Heart Association functional class rating symptoms and exercise tolerance times improved on captopril but not on nifedipine. The reduction in pulmonary capillary wedge pressure and the increase of cardiac output on captopril indicated that the augmented functional capacity may have resulted in part from an improved performance of the left ventricle. Although there were comparable decreases in systemic vascular resistance and presumably in impedence to ejection by the left ventricle on both drugs, the dimensions of the ventricular cavity were found to be reduced by captopril and augmented by nifedipine, and only captopril reduced the afterload (wall stress). In addition, the force-length relation (between left ventricular end systolic stress and end systolic diameter) was shifted to the left of baseline by captopril and to the right by nifedipine, suggesting that muscle contractility was reduced by nifedipine and not by captopril. These results suggest that nifedipine and captopril have different effects on afterload and contractility and these may account for the different effects of these drugs on the performance of the heart and clinical responses.

AB - Nifedipine and captopril are potent vasodilators and may be expected to help left ventricular failure by reducing afterload. Nifedipine (20 mg three times a day) and captopril (50 mg three times a day) were added to an optimal regimen of digitalis and diuretics in a double blind crossover trial in 18 cases of dilated cardiomyopathy. New York Heart Association functional class rating symptoms and exercise tolerance times improved on captopril but not on nifedipine. The reduction in pulmonary capillary wedge pressure and the increase of cardiac output on captopril indicated that the augmented functional capacity may have resulted in part from an improved performance of the left ventricle. Although there were comparable decreases in systemic vascular resistance and presumably in impedence to ejection by the left ventricle on both drugs, the dimensions of the ventricular cavity were found to be reduced by captopril and augmented by nifedipine, and only captopril reduced the afterload (wall stress). In addition, the force-length relation (between left ventricular end systolic stress and end systolic diameter) was shifted to the left of baseline by captopril and to the right by nifedipine, suggesting that muscle contractility was reduced by nifedipine and not by captopril. These results suggest that nifedipine and captopril have different effects on afterload and contractility and these may account for the different effects of these drugs on the performance of the heart and clinical responses.

UR - http://www.scopus.com/inward/record.url?scp=0022650122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022650122&partnerID=8YFLogxK

M3 - Article

VL - 55

SP - 391

EP - 399

JO - British Heart Journal

JF - British Heart Journal

SN - 0007-0769

IS - 4

ER -